• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Biotech Market
Biotech News
Biotech Stocks
  • Biotech Market
  • Biotech News
  • Biotech Stocks

InspireMD Signs Distribution Agreement with Arteriae

Written by Bryan Mc Govern
|
Jun. 05, 2017 09:51AM PST

InspireMD signed an agreement with Arteriae, a medical distributor leader in Poland, to distribute CGuard Embolic Prevention System.

InspireMD (NYSEMKT:NSPR) signed an agreement with Arteriae, a medical distributor leader in Poland, to distribute CGuard Embolic Prevention System.
As quoted in the press release:

Agustin Gago, EVP and Chief Commercial Officer of InspireMD, commented, “We are delighted to partner with Arteriae, a leading device distributor in Poland. The agreement includes minimum required purchases, reinforcing Arteriae’s confidence in our device. Arteriae brings strong relationships with the top key opinion leaders and physicians across all relevant clinical specialties and plans to expand its sales force to focus on CGuard™ EPS. Importantly, this agreement further illustrates our success in expanding our direct distribution model in markets previously covered by our former distributor.”
Mrs. Joanna Niedzielska, CEO of Arteriae, noted, “We look forward to aggressively launching CGuard™ in Poland. Given the important safety advantages of CGuard™ that have been demonstrated to date, our near-term goal is to capture a significant share of the Polish market and we believe this device will soon become standard of care.”

Click here to read the full press release.

Source: www.marketwired.com

cguard eps embolic prevention system nyse:mkt
The Conversation (0)

Go Deeper

AI Powered
Cardiex Limited (ASX:CDX)

Cardiex Limited

Evercore ISI Ranked No. 1 in Extel All-America Research Survey for 4th Straight Year

Latest News

Outlook Reports world

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
  • Energy
    • Uranium
    • Oil and Gas
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Industrial Metals
  • Agriculture
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Gaming
    • Cleantech
    • Emerging Tech
Life Science
    • Biotech
    • Cannabis
    • Psychedelics
    • Pharmaceuticals

Featured Biotech Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES